Why It’s Crucial to Address Insulin Resistance During Pregnancy

With its potential to pose significant health risks for both mothers and their newborns, severe insulin resistance warrants increased attention throughout pregnancy.

Likewise, within the “fragmented” coordination of health care in the US, experts like Clipper Young, PharmD, MPH, CDCES, BC-ADM, BCGP, professor at the Touro University California College of Osteopathic Medicine, believe a multidisciplinary approach to addressing insulin resistance is also necessary.

“By addressing severe insulin resistance during pregnancy, we have an opportunity to potentially break that intergenerational cycle of metabolic conditions and really pave the way, hopefully, for healthier future generations,” Young told Drug Topics.

He joined us in part 3 to discuss the importance of addressing insulin concerns among mothers and their children. Throughout our interview with Young, he explored a variety of topics within both the diabetes space as well as the community pharmacy industry as a whole.

Addressing some of the published literature he’s contributed to, Young discussed the diabetes links between mothers and newborns, the growing concerns surrounding severe insulin resistance particularly, and the overall importance of leveraging multiple health care providers’ expertise.

“The coordinated multidisciplinary strategy is very important,” he continued. “We want to advocate [and] we are advocating for a framework that can address problems at [multiple] levels.”

READ MORE: Insulin Management Resource Center

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.